Ohguchi, Hiroto
Hideshima, Teru
Anderson, Kenneth C.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P50-CA100707, R01-CA178264, P50-CA100707, R01-CA050947, R01-CA178264)
Article History
Received: 19 May 2018
Revised: 20 July 2018
Accepted: 31 July 2018
First Online: 22 August 2018
Change Date: 6 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41408-021-00559-4
Conflict of interest
: H.O. and T.H. declare that they have no conflict of interest. K.C.A. serves on advisory boards for Celgene, Millennium, and Gilead Sciences, and is a scientific founder of OncoPep and C4 Therapeutics.